Papers
5
Total Citations
37
H-Index
3
About
Jen-Shu Tseng is a leading urologic oncologist whose research focuses on optimizing surgical management for upper tract urothelial carcinoma (UTUC), a particularly prevalent cancer in Taiwan. Dr. Tseng’s major contributions center on comparing minimally invasive nephroureterectomy techniques—hand-assisted, laparoscopic, and robotic—to determine which offers the best oncological outcomes and fewest complications. Their landmark 2021 study (24 citations) provided critical evidence that robotic and laparoscopic approaches can match open surgery for early-stage UTUC, while a 2024 multicenter analysis extended these findings to locally advanced T3T4 disease, challenging the prevailing skepticism about minimally invasive surgery in complex cases. Dr. Tseng has also advanced organ-preserving strategies through segmental ureterectomy research and systematically evaluated bladder cuff excision techniques in a large 19-hospital collaborative study. Beyond UTUC, their work on Hem-o-Lok clip migration after robotic prostatectomy highlights a practical surgical safety concern. As a key member of the Taiwan UTUC Collaboration Group, Dr. Tseng’s research directly shapes clinical guidelines in a high-endemic region, offering urologists evidence-based pathways to reduce morbidity while maintaining cancer control.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5